NCT00705289View on ClinicalTrials.gov

A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

CompletedOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Infliximab

Infliximab used in line with current clinical practice and local guidelines.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00705289 - A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) | Biotech Hunter | Biotech Hunter